Acurx Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.17 | -$0.17 | -$0.17 |
| Q2 2024 | 1 | -$0.15 | -$0.15 | -$0.15 |
| Q3 2024 | 1 | -$0.18 | -$0.18 | -$0.18 |
| Q1 2025 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q2 2025 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q3 2025 | 1 | -$0.59 | -$0.59 | -$0.59 |
| Q4 2025 | 1 | -$0.59 | -$0.59 | -$0.59 |
Acurx Pharmaceuticals, Inc. Earnings Date And Information
Acurx Pharmaceuticals, Inc. last posted its earnings results on Friday, August 9th, 2024. The company reported $-0.26 earnings per share for the quarter, topping analysts' consensus estimates of $-0.28 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Acurx Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-1.15 diluted earnings per share) and currently has a price-to-earnings ratio of -0.01. Acurx Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based on prior year's report dates.
Acurx Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 2024 | -$172.43 | $0 | $0 | ||
| 08/08/2024 | Q2 2024 | -$0.26 | $0 | $0 | ||
| 05/14/2024 | Q1 2024 | -$0.24 | -$0.28 | -0.04 | $0 | |
| 03/15/2024 | Q4 2023 | -$0.26 | -$0.38 | -0.12 | $0 | |
| 11/13/2023 | Q3 2023 | -$0.28 | -$0.24 | 0.04 | $0 | |
| 08/11/2023 | Q2 2023 | -$0.28 | $0 | |||
| 05/12/2023 | Q1 2023 | -$0.34 | -$0.25 | 0.09 | $0 | |
| 03/15/2023 | Q4 2022 | $0.18 | $0 | |||
| 11/10/2022 | Q3 2022 | -$0.32 | $0 | |||
| 08/12/2022 | Q2 2022 | -$0.26 | $0 | |||
| 05/10/2022 | Q1 2022 | -$0.26 | $0 | |||
| 03/16/2022 | Q4 2021 | -$0.38 | $0 | |||
| 11/12/2021 | Q3 2021 | -$0.46 | $0 | |||
| 08/13/2021 | Q2 2021 | -$0.57 | $0 | |||
| 03/31/2021 | Q1 2021 | -$0.15 | $0 | |||
| 12/30/2020 | Q4 2020 | -$0.11 | $0 | |||
| 09/30/2020 | Q3 2020 | -$0.14 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.10 | $0 | |||
| 03/31/2020 | Q1 2020 | -$0.13 | $0 |
Acurx Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Acurx Pharmaceuticals, Inc.'s earnings date?
Acurx Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates.
-
Did Acurx Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Acurx Pharmaceuticals, Inc. (:ACXP) reported $-0.26 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.28 by $0.02.
-
How can I listen to Acurx Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Acurx Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Acurx Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Acurx Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does Acurx Pharmaceuticals, Inc. generate each year?
Acurx Pharmaceuticals, Inc. (:ACXP) has a recorded net income of $0. Acurx Pharmaceuticals, Inc. has generated $-1.15 earnings per share over the last four quarters.
-
What is Acurx Pharmaceuticals, Inc.'s price-to-earnings ratio?
Acurx Pharmaceuticals, Inc. (:ACXP) has a price-to-earnings ratio of -0.01 and price/earnings-to-growth ratio is 0.
